|
?:authorAffiliation
|
-
[\'São Carlos Institute of Chemistry, University of São Paulo, São Carlos, SP, 13560-970, Brazil.\', \'Biolinker Synthetic Biology EIRELI, São Paulo, 05508-000, Brazil.\', \'Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Clinical Hospital HCFMUSP, Faculty of Medicine, University of São Paulo, São Paulo, 01246903, Brazil; Division of Research and Transfusion Medicine, São Paulo Hemocentre Pro-Blood Foundation, São Paulo, 05403000, Brazil.\', \'Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, 05403-000, Brazil; LIM-46 HC-FMUSP - Laboratory of Medical Investigation, Clinical Hospital, Faculty of Medicine, University of São Paulo, 01246903, Brazil.\', \'Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, 05403-000, Brazil.\', \'São Carlos Institute of Chemistry, University of São Paulo, São Carlos, SP, 13560-970, Brazil. Electronic address: frankcrespilho@iqsc.usp.br.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}